HR. 5526In Committee
Biosimilar Red Tape Elimination Act
Eliminate regulatory requirements identified as red tape for biosimilar products
Plain-English overview
What this bill does
Eliminate regulatory requirements identified as red tape for biosimilar products
Key points
- Repeal biosimilar regulatory requirements
Current status
Where it stands
Status
In Committee
Latest action
2025-09-19 — Referred to the House Committee on Energy and Commerce.
Related context
Topics and policy areas
undefinedHealth